KINETA INC.
KINETA INC.
Share · US49461C1027 · KA · A3D2GA (XNCM)
Overview
No Price
n/a
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
Share Float & Liquidity
Free Float 65,11 %
Shares Float 7,98 M
Shares Outstanding 12,26 M
Company Profile for KINETA INC. Share
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

Company Data

Name KINETA INC.
Company Kineta, Inc.
Symbol KA
Website https://kinetabio.com
Primary Exchange XNCM Frankfurt
WKN A3D2GA
ISIN US49461C1027
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Craig W. Philips
Country United States of America
Currency EUR
Employees 0,0 T
Address 219 Terry Ave. N, 98109 Seattle
IPO Date 2016-02-11
Dividends from 'KINETA INC.'
Ex-Date Dividend per Share
19.12.2022 1,43 USD

ID Changes

Date From To
19.12.2022 YMTX KA
23.12.2020 PTI YMTX

Ticker Symbols

Name Symbol
NASDAQ KA
More Shares
Investors who hold KINETA INC. also have the following shares in their portfolio:
890 5th Avenue Partners, Inc.
890 5th Avenue Partners, Inc. Share
TOYOTA FIN.AUSTR.17/22MTN
TOYOTA FIN.AUSTR.17/22MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025